Compound ID | 1810

Globomycin

Class: Lipopeptide

Spectrum of activity: Gram-positive  &  Gram-negative
Details of activity: Inhibits signal peptidase II (LspA), an enzyme involved in lipoprotein posttranslational processing in bacteria
Description: Streptomyces natural product. Globomycin semisynthetic analog G0790
Institute where first reported: Sankyo Co
Year first mentioned: 1978
Highest developmental phase: Preclinical
Development status: Inactive (as of 2022)
Chemical structure(s):
Click here for structure editor
Molecular weight: 655.82
Iso. SMILES: CCCCCCC1C(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)O1)C(C)O)CO)C(C)CC)CC(C)C)C)C
InChI Key: VFGBXFZXJAWPOE-UHFFFAOYSA-N
Can. SMILES: CCCCCCC1C(C)C(=O)N(C)C(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)NCC(=O)O1
InChI: InChI=1S/C32H57N5O9/c1-9-11-12-13-14-24-20(6)32(45)37(8)23(15-18(3)4)29(42)35-26(19(5)10-2)31(44)34-22(17-38)28(41)36-27(21(7)39)30(43)33-16-25(40)46-24/h18-24,26-27,38-39H,9-17H2,1-8H3,(H,33,43)(H,34,44)(H,35,42)(H,36,41)

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.